Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'd suggest you call Sara Bonstein, the ADXS CFO. She knows EVERYTHING that concerns ADXS shareholders, who the shorts are, why ADXS management has done NOTHING to eliminate the shorts etc. Don't let her try to send you to the IR who knows nothing.
This is Sara Bonstein's, ADXS CFO, direct phone number: 609-250-7510. As the CFO, she knows who all the shorts are. Got questions about the shorts or anything else, ask her, not the IR.
This is Sara Bonstein's, ADXS CFO, direct phone number: 609-250-7510. As the CFO, she knows who all the shorts are. Got questions about the shorts or anything else, ask her, not the IR.
PCFG status is dissolved.
Business Entity Information
Status: Dissolved File Date: 12/20/1996
Type: Domestic Corporation Entity Number: C26330-1996
Qualifying State: NV List of Officers Due: 12/31/2017
Managed By: Expiration Date:
Foreign Name: On Admin Hold: No
NV Business ID: NV19961249193 Business License Exp: 12/31/2017
This is Sara Bonstein's, ADXS CFO, direct phone number: 609-250-7510. As the CFO, she knows who all the shorts are. Got questions about the shorts or anything else, ask her, not the IR.
Zimbabwe political & country risk greatly intensifies for Caledonia Mining shareholders in addition to fundamental problems with 49% owned Blanket mine.
Zim now back to 2008 doom
September 25, 2017 2:00 AM
Source: Zim now back to 2008 doom | Daily News
Mugove Tafirenyika • 24 September 2017
HARARE – Experts have issued a fresh warning that the country is now a touch away from an economic disaster similar to the meltdown of 2008 when local inflation hit world record levels and supermarket shelves went empty for months on end.
This comes as there is growing panic among jittery Zimbabweans who are stampeding to hoard basic consumer goods in light of the country’s worsening foreign currency shortages and the resurfacing of long fuel queues at most service stations.
In the meantime, the under-pressure Reserve Bank of Zimbabwe (RBZ) has called for calm, saying reports of shortages of both bond notes and basic goods are exaggerated — even as many shops in urban areas at the weekend did not have adequate supplies of sugar, cooking oil and washing powder.
Economic experts who spoke to the Daily News on Sunday yesterday said they had little doubt that the country was now headed for the “doom and gloom” of 2008 when Zimbabwe experienced unprecedented socio-economic problems characterised by shortages of fuel, basic foodstuffs and drugs.
They pointed to the burgeoning parallel forex market, the complete disappearance of the much coveted United States dollar, the collapse of bond notes and the skyrocketing prices of most consumer goods as “grave indicators” of a tough road ahead.
However, and against the experience of ordinary Zimbabweans on the ground, RBZ governor John Mangudya appealed for calm, also dismissing reports of shortages of basic commodities.
“The Reserve Bank of Zimbabwe would like to advise the Zimbabwean public to dismiss the social media messages that are circulating and suggesting that there is going to be a shortage of basic commodities.
“These messages are meant to cause panic and despondency and mayhem to the unsuspecting and peace loving members of the public. All such and other statements should be dismissed with the contempt they deserve,” Mangudya said in a statement.
“Peddling of such fake news is quite unfortunate. There are no shortages of basic commodities. On the contrary, foreign exchange currently being allocated for basic and essential commodities has instead been increased to ensure that shortages of commodities do not occur within the economy.
“Zimbabweans should refuse to be hoodwinked by fake social media statements designed to increase premiums on the parallel markets by misguided rent seekers.
“In addition, the minister of Finance and Economic Development did not print bond notes to buy US dollars from the streets.
“Such malicious statements are counter-productive and are meant to sabotage the economy that is on the rebound on account of the good agricultural out-turn, strong performance of the mining sector and the recovery of the manufacturing sector,” Mangudya added.
This hard-hitting central bank statement notwithstanding, most service stations in Harare were dry yesterday — and where fuel was available, there were long queues as motorists rushed there to fill up their vehicles.
Similarly, local pharmacies are also struggling to stock critical drugs due to the biting foreign currency challenges in the country, forcing them to also hike the prices of essential medicines.
Zimbabwe is relying on foreign imports for its much-needed drugs, medicare equipment and other hospital consumables. It imports more than $400 million worth of basic drugs each year.
At the same time, the RBZ says it has a backlog of $600 million on its imports bill books, although analysts say the correct figure is closer to $1 billion.
Apart from failing to access foreign currency at local banks, ordinary Zimbabweans have over the past few weeks been greeted by sharp increases in the prices of basic goods, as retailers hike prices continually in response to the high cost of money on the parallel market.
Yesterday, one US dollar was trading against the bond note at up to 1,40 on the parallel market, while bank transfers were being transacted at 1,60 bond notes for one greenback.
The majority of companies which fall outside the RBZ’s priority list for foreign currency rely on bank transfers for their needs, via the parallel market.
As a result, prices of basic consumer goods have been shooting up sharply as companies and retailers pass on their exchange costs to ordinary Zimbabweans.
“There has been a surge in prices of most goods owing to the cost of money on the parallel market. Most manufacturers and importers are resorting to the illegal market for foreign payments for raw materials and other critical goods.
“The high cash premiums are causing serious price distortions on the market. This is hurting the economy and consumers . . . as business is simply passing on the cost of money to customers,” Confederation of Zimbabwe Retailers president Denford Mutashu told our sister paper, the Daily News recently.
Many companies, including those on the authorities’ priority list which import raw materials, have almost given up on the RBZ route as approvals of their foreign currency applications are taking long to bear fruit.
Zimbabwe is currently in the grip of a serious economic crisis which has resulted in severe cash shortages and the complete disappearance of US dollars from the formal market.
“That Zimbabwe is still using the United States dollar as currency is pure fiction. Zimbabwe abandoned the US dollar as currency way back in 2013 after the elections. The government did it nicodemously when we all weren’t looking.
“This was partly driven by greed, partly by Zanu PF’s cluelessness and partly by the party’s perpetual electoral mode — it campaigns more than it governs.
“What does this all mean? It simply means that we are back on the same road as we were from 2006 to 2008. The ghosts of shortages and inflation are creeping in,” economic analyst Matt Matigari said.
“All Mangudya and his principals can do is just patch holes … That my friends, is what we are facing. There is no point in sugarcoating reality because there is no Sugar Candy Mountain anywhere near.
“(President) Robert Mugabe is the only president with the unique distinction of battering two different currencies in his lifetime and within a space of 15 years. He did not just ruin the Zimbabwe dollar, but also tore apart the United States dollar as we knew it from 2009 to 2013.
“The present government has proven, not once, but twice that they are clueless and cannot address the fundamentals. In its current configuration, the government will never change our trajectory. Serious inflation is coming and so are all the problems we have experienced before,” Matigari added.
Former Finance minister Tendai Biti, who was credited with steering the economy from the danger zone shortly after the formation of the inclusive government in 2009, warned of worse things to come.
“The wheels have come off completely and the irony is that we are in a recession with inflationary tendencies and this is a sign of failure on the party of government,” he said.
The reason the shorts haven't covered is the shorts, like BP know that AXAL is a dud & won't get FDA or EU approval.
Proves that they are bozos because if they believed their own recommendations, that ADXS will be a $40 stock, they would be buying big time at $4.30, but they aren't. They won't put their money where their mouths are. So much for these geniuses.
Not a bad thing, just nothing special as the collapsing share price proves.
"So you have proof that they lied about having the best results to date?" The collapsing share price proves the "best results to date" means absolutely NOTHING.
IF the GOG phase 2 trial was so "stellar", ADXS share price would not be collapsing to new 52 week lows almost daily. The fallacy of the manipulation excuse is that the "manipulators" could make a lot more money manipulating the ADXS share price up, than they can make manipulating it down. The "manipulators must be total idiots.
CMCL target price $9, LOL. The $9 price does not even break the triple top at $10.95 that has been in place since 2008 & CMCL was $9.26 last year. CMCL share price is being punished by the market because of the very poor Q2 results & poor guidance. If not for the dividend to support the share price, CMCL would be a penny stock.
Adage & the other tutes should be backing up the truck & buying at these low prices IF they believed that AXAL is the real deal, but they are not. The tutes loved ADXS at an average price of $12, they should be love it even more at $4.40, but they don't. It's not a matter of patience, it's that they know AXAL is a dud & no FDA or EU approval.
Adage & the other tutes could easily explode the share price to the upside by buying big time right now. That would force the shorts to cover. However the tutes refuse to buy for the same reason no BP wants to buy out ADXS at this "supposed" miniscule, undervalued market cap. They know AXAL is a dud & it won't get FDA or EU approval.
The reason to sell & the reason ADXS has collapsed in price is & always has been the same. It's not HFT, evil market maker manipulation or any other lame excuses posted on this board. The stone cold reason is the market, the shorts & BP all know that AXAL is a dud, will not get FDA approval or EU approval. That's the bottom line.
tin, why do you think, given the "supposed" decent AXAL trial results so far & phase 3 starting, possible EU submission shortly, a totally crushed share price & a GREATLY reduced market cap, that the shorts refuse to cover & that no big pharma, especially AMGEN, wants to buy out ADXS at this fire sale price? It appears that the shorts & big pharma believe AXAL is a dud, will not get FDA approval & that the EU submission will either be turned down or will mean very little. What say you?
tin, is it possible that the bumbling ADXS management could do the right thing & extend the expiration date of the warrants for another 3 years because of ADXS management incompetence?
The shorts & BP know AXAL will not get FDA approval because AXAL is a dud. ADXS will be a penny stock if NO EU approval which is likely as the stock would not be collapsing if EU approval is in the cards.
Sure would like to know what Dr. Yvonne Paterson thinks about the company she chose to move her invention AXAL to market, getting destroyed & her dream possibly crushed by totally incompetent ADXS management.
Here's Why Advaxis, Inc. Stock Is Getting Pummeled Today
Despite a lack of particularly damaging news, investors are losing patience with this biotech.
Cory Renauer
Sep 12, 2017 at 12:34PM
What happened
Shares of Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotech developing novel cancer immunotherapies, are sinking after the company provided a business update along with a third-quarter earnings report after the bell yesterday. Investors weren't impressed with the amount of progress achieved so far this year, driving the stock 16.4% lower as of 11:50 a.m. EDT during Tuesday's trading session.
So what
Advaxis' core technology involves altering a strain of Listeria bacteria in a way that stimulates patient immune cells to recognize and attack cancer cells. The company is still preparing a marketing application submission for European regulators that it expects to complete by the end of the year. If accepted, it could lead to conditional approval to treat certain forms of cervical cancer.
This July, the company bid adieu to CEO Daniel J. O'Connor, and it's been troubling that a permanent replacement has not been found. Tony Lombardo, who joined the company earlier in the year, quickly stepped in as interim CEO. Comments from the chairman stating he would remain in his position for the foreseeable future suggest qualified applicants aren't exactly beating a path to Advaxis' human resources department.
Now what
Advaxis intends to begin a combination study with Opdivo from Bristol-Myers Squibb that could lead to another application for treatment of cervical cancer, but the study isn't slated to begin until next year. The company also has another candidate, ADXS-PSA, in early-stage combination therapy trials with Keytruda from Merck & Co. that could lead to a prostate cancer application. Unfortunately, it will be a long time before we can make any conclusions about Advaxis' novel immunotherapies ability to boost the efficacy of blockbuster drugs from its big pharma peers.
The company finished its fiscal third quarter with about $89.4 million in cash and investments after losing $70.2 million during the nine months leading up to the end of July. At this rate, it looks like investors should brace for another share offering before European regulators issue a decision regarding an application that hasn't even been submitted yet. With this in mind, it might be best to watch this show from the sidelines.
The reason ADXS share price continues to collapse, why the shorts don't cover & why there is no buy out by BP is because the market, the shorts & BP know that AXAL is a dud & will not get FDA approval.
Earnings out after the close today. Perhaps that is why ADXS is getting hammered.
CMCL is not participating in the gold stock rally. CMCL is being severely punished by the market for the incredibly poor performance of CMCL's ONLY gold property, the Blanket mine, last quarter. This clearly displays the very high risk & the folly of CMCL owning only a minority interest in one gold property in the Zimbabwe.
Nothing is automatic expect death & taxes.
Quite a battle going on around the $6 level.
We do know which tutes are well informed. It's the tutes that sold out their entire position in spite of all the "supposed" great things that are projected to happen for ADXS in the next 6 months.
What makes you think that these very informed & sophisticated shorts did not provide themselves with a way to cover? These shorts have been right all along & probably have a plan where they will get the shares to cover. Tin may be right. Could be they will get them from ADXS itself. It is nothing but pure hopium to believe they have no way to cover other than to cover in the open market.
To bad the selling tutes & the shorts don't agree with your assessment. Why aren't the tutes buying big time instead of selling & why are the shorts not covering?
Not my opinion, it's the belief of the shorts & the tutes.
Got to wonder if the tutes believed in AXAL why, knowing the monster short position in the stock, did the tutes not significantly increased their ADXS position & FORCE the shorts to cover exploding the stock to much higher prices which is in their own best interest.
It's not my opinion, it's what the tutes & shorts believe. If the tutes believed AXAL was going to get FDA approval, NO WAY they would have sold out their total ADXS positions especially with DO now history.
IF Broadfin sold out because of DO as you claim, then why hasn't Broadfin bought back in at much lower prices now that DO has left the building? Broadfin sold, just as all the other selling tutes sold, because they believe that AXAL is a dud & will NOT get FDA approval.
The science has NOT proved AXAL to be the real deal by the clinical trial results. The shorts & selling tutes know that AXAL will NOT get FDA approval. That is why the shorts have not covered yet & the selling tutes completely sold out their ADXS positions.
CMCL's poor Q2 earnings report clearly displays the very high risk in CMCL owning only a 49% interest in one gold mine in Zimbabwe. CMCL needs to buy, merge, acquire or joint venture new profitable gold properties outside Zimbabwe now that CMCL is listed on the NYSE AMEX.
What you missed is that some tutes are more well informed than others. Just like the shorts are much more well informed than ADXS shareholders who HAVE to believe in AXAL or admit to themselves that they made a big mistake in buying & holding ADXS. They can't allow themselves to believe that their dreams of riches, glory & retirement are just an ADXS hopium induced delusion.
Don't Bogart that joint my friend, pass it over to me.
The tutes obviously think you are dead wrong about AXAL. That is why they dumped their shares. The tutes know a lot more than you.
A man hears only what he wants to hear and disregards the rest.
If the tutes that sold believed that AXAL is the real deal and would be FDA approved, NO WAY they would have sold. It's just that simple.
Broadfin, and the other tutes who dumped their shares did so because they, like BP, believe that AXAL is a dud & will not be FDA approved.